Severe Multi-Resistant Pemphigus vulgaris: prolonged remission with a single cycle of Rituximab

Pemphigus vulgaris is an autoimmune bullous disease whose therapy is based on systemic corticosteroids, with or without immunosuppressants. Rituximab is a chimeric monoclonal antibody of the IgG class, directed at a specific CD20 B cell surface antigen, used in pemphigus vulgaris empirically since 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Corral, Isabela Soubhia, de Freitas, Thais Helena Proença, de Aquino, Renata Telles Rudge, Koller, Daniella Abbruzzini S., Magliari, Maria Elisa Ruffolo, Muller, Helena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Dermatologia 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3760947/
https://www.ncbi.nlm.nih.gov/pubmed/24068143
http://dx.doi.org/10.1590/abd1806-4841.20131990

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3760947/
https://www.ncbi.nlm.nih.gov/pubmed/24068143
http://dx.doi.org/10.1590/abd1806-4841.20131990

Ejemplares similares